
|Videos|August 28, 2017
Dr. Siegel on Induction Therapy for Head and Neck Cancer
Author(s)Robert Siegel, MD
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.
Advertisement
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.
In head and neck cancer, when physicians are using induction therapy there have been 3 drugs that have been used, states Siegel. These are docetaxel, cisplatin, and 5-flourouracil (5-FU). According to Siegel, 5-FU adds more toxicity than efficacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5




































